See also this year's filing and all EDGAR filings for this company.
PDF Report 0001157601_2022_Madrigal_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.8460999166948474, 'aggregate_val': 447646000, 'exp_sum': 242482000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 37318000, 'ResearchAndDevelopmentExpense': 205164000, 'remainder_Expenses': 0}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.8249147159157746, 'aggregate_val': 542976000, 'exp_sum': 297535000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 48130000, 'ResearchAndDevelopmentExpense': 245441000, 'remainder_Expenses': 3964000}} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001157601, Madrigal Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 271,684,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 851,000 |
| 3 | remainder_Assets | 797,000 |
| 4 | LiabilitiesCurrent | 76,838,000 |
| 5 | LiabilitiesNoncurrent | 387,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,306,371 |
| 9 | ResearchAndDevelopmentExpense | 212,326,359 |
| 10 | remainder_Expenses | 207,683,362 |
| 11 | remainder_Revenues | 215,994 |
| 12 | remainder_NetIncome | -1,025,567 |
| 13 | remainder_ComprehensiveNetIncome | -122,345 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 273,332,000 |
| 1 | Liabilities | 77,225,000 |
| 2 | Expenses | 456,316,092 |
| 3 | Revenues | 215,994 |
| 4 | StockholdersEquity | 196,107,000 |
| 5 | NetIncome | -457,125,665 |
| 6 | ComprehensiveNetIncome | -457,186,838 |
| 7 | BaseVar | 404,118,499 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.169 |
| 9 | EconomicCapitalRatio | 1.41 |